Literature DB >> 2824564

Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

K A Bauer1, L M Weiss, D Sparrow, P S Vokonas, R D Rosenberg.   

Abstract

In view of the known association of vascular disease with increasing age, we have conducted an analysis of hemostatic system activity with respect to perturbations induced by aging phenomena. We have utilized an immunochemical assay for prothrombin fragment F1 + 2 to quantify Factor Xa activity upon prothrombin in the plasma of 199 healthy males between the ages of 42 and 80. The levels of F1 + 2 in this population generally increased as a function of age (P less than 0.0001). The metabolic behavior of this marker was determined in 10 individuals greater than 65 yr of age with varying levels of F1 + 2, which ranged from 1.28 to 5.85 nM. The elevations in the concentration of this component were not due to diminished clearance of the fragment. Radio-immunoassays for fibrinopeptide A (FPA) and the protein C activation peptide (PCP) were subsequently employed to measure thrombin activity upon fibrinogen and thrombin-thrombomodulin activity upon protein C, respectively, in 82 members of this population ranging in age from 42 to 80. Significant positive correlations were again observed between increasing age and the level of F1 + 2 (P less than 0.0001) as well as FPA (P less than 0.01) and PCP (P less than 0.002). The results of this cross-sectional study indicate that many apparently normal males of increasing age with normal immunologic levels of antithrombin III and protein C exhibit a biochemical defect that denotes the presence of an acquired prethrombotic state.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824564      PMCID: PMC442420          DOI: 10.1172/JCI113238

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  The release of a human platelet specific protein measured by a radioimmunoassay.

Authors:  C A Ludlam; S Moore; A E Bolton; D S Pepper; J D Cash
Journal:  Thromb Res       Date:  1975-06       Impact factor: 3.944

2.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

3.  Statistical characterization of the random errors in the radioimmunoassay dose--response variable.

Authors:  D Rodbard; R H Lenox; H L Wray; D Ramseth
Journal:  Clin Chem       Date:  1976-03       Impact factor: 8.327

4.  A radioimmunoassay for platelet factor 4.

Authors:  A E Bolton; C A Ludlam; D S Pepper; S Moore; J D Cash
Journal:  Thromb Res       Date:  1976-01       Impact factor: 3.944

Review 5.  Analysis of disappearance time-curves after single injection of labelled proteins.

Authors:  B Nosslin
Journal:  Ciba Found Symp       Date:  1972

Review 6.  Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

Authors:  D Rodbard
Journal:  Clin Chem       Date:  1974-10       Impact factor: 8.327

7.  Human prothrombin metabolism in normal man and in hypocoagulable subjects.

Authors:  S S Shapiro; J Martinez
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

8.  Radioimmunoassay of human fibrinopeptide A.

Authors:  H L Nossel; L R Younger; G D Wilner; T Procupez; R E Canfield; V P Butler
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

9.  Measurement of fibrinopeptide A in human blood.

Authors:  H L Nossel; I Yudelman; R E Canfield; V P Butler; K Spanondis; G D Wilner; G D Qureshi
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

10.  The effect of age upon the coagulation system.

Authors:  P J Hamilton; M Allardyce; D Ogston; A A Dawson; A S Douglas
Journal:  J Clin Pathol       Date:  1974-12       Impact factor: 3.411

View more
  28 in total

1.  Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Risk factors for thromboembolism: pathophysiology and detection.

Authors:  S Solymoss
Journal:  CMAJ       Date:  2000-10-17       Impact factor: 8.262

3.  A mathematical model of the background state of the blood coagulation system.

Authors:  I F Obraztsov; D V Kardakov; A E Kogan; M A Khanin
Journal:  Dokl Biochem Biophys       Date:  2001 Jan-Feb       Impact factor: 0.788

Review 4.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

5.  Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation.

Authors:  Satoshi Ueshima; Daiki Hira; Chiho Tomitsuka; Miki Nomura; Yuuma Kimura; Takuya Yamane; Yohei Tabuchi; Tomoya Ozawa; Hideki Itoh; Minoru Horie; Tomohiro Terada; Toshiya Katsura
Journal:  AAPS J       Date:  2019-06-24       Impact factor: 4.009

6.  Thrombotic preparedness in aging: a translatable construct for thrombophilias?

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2007-09-29       Impact factor: 2.300

7.  Atrial fibrillation and stroke: what we know, what's new, and what we should do now.

Authors:  C S Landefeld
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

8.  Nonvalvular atrial fibrillation: evidence for a prothrombotic state.

Authors:  S R Kahn; S Solymoss; K M Flegel
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

Review 9.  Role of TRPC6 in Progression of Diabetic Kidney Disease.

Authors:  Alexander Staruschenko; Denisha Spires; Oleg Palygin
Journal:  Curr Hypertens Rep       Date:  2019-05-21       Impact factor: 5.369

10.  Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.

Authors:  E M Conway; K A Bauer; S Barzegar; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.